Your browser doesn't support javascript.
loading
Fasting before contrast-enhanced CT and the incidence of acute adverse reactions: a single-center randomized clinical trial.
Zitan Saidi, Laila; Moreira Cabrera, Maricela; Góngora Lencina, Teresa; Marín Morón, Fuensanta; Alarcón Rodríguez, Raquel; García González, Jessica.
Afiliação
  • Zitan Saidi L; Department of Diagnostic Imaging, Torrecárdenas University Hospital, Almería, Spain.
  • Moreira Cabrera M; Department of Diagnostic Imaging, Vall d'Hebron University Hospital, Barcelona, Spain. moreiramaricela@gmail.com.
  • Góngora Lencina T; Department of Diagnostic Imaging, Torrecárdenas University Hospital, Almería, Spain.
  • Marín Morón F; Department of Diagnostic Imaging, Torrecárdenas University Hospital, Almería, Spain.
  • Alarcón Rodríguez R; Department of Nursing, Physiotherapy and Medicine, Faculty of Health Sciences, University of Almería, Almería, Spain.
  • García González J; Department of Nursing, Physiotherapy and Medicine, Faculty of Health Sciences, University of Almería, Almería, Spain.
Insights Imaging ; 15(1): 195, 2024 Aug 07.
Article em En | MEDLINE | ID: mdl-39112723
ABSTRACT

OBJECTIVES:

To evaluate the effect of eliminating the traditional preparatory fasting policy before contrast-enhanced CT on acute adverse reactions and to identify potential risk factors in a Spanish population sample, since many European patients still experience this unnecessary measure in clinical practice.

METHODS:

Outpatients who underwent non-emergency CT to either 6 h of solid food fasting (control group) or an unrestricted consumption of solids (intervention group). Adverse reactions during contrast media administration and up to 30 min afterward were recorded and their incidence was calculated. Using univariate and multivariate logistic regression analyses, various patient-related and technical factors were evaluated to identify risk factors for nausea and vomiting.

RESULTS:

One thousand one hundred three patients were evaluated, 560 patients in the control group, and 543 patients in the intervention group. Moderate and severe acute adverse reactions were not identified in either group. No statistical difference was found in the overall acute adverse reactions (hypersensitivity and chemotoxicity) incidence between groups (3.21% vs 2.30% p = 0.36). The total incidence of emetic adverse reactions (nausea and vomiting) was significantly lower in the intervention group than in the control group (0.92% vs 2.86% p = 0.02). Multivariate logistic regression analysis revealed that fasting, age, allergies, neurological diseases, and contrast media concentration were independent risk factors for nausea and vomiting.

CONCLUSION:

Unrestricted food intake did not increase the overall incidence of acute adverse reactions and diminished the incidence of nausea and vomiting. TRIAL REGISTRATION ANZCTR, ACTRN12623000071628. Registered 23 January 2023-retrospectively registered, https//www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=384985&showOriginal=true&isReview=true . CRITICAL RELEVANCE STATEMENT This randomized clinical trial carried out in adults undergoing a non-emergent CT scan demonstrates that fasting as a preparation before a contrast-enhanced CT scan should be discontinued and reserved only for certain specific imaging tests. KEY POINTS Despite low osmolar CT contrast media becoming ubiquitous, preparatory fasting is still widely practiced. The overall incidence of acute adverse reactions was unchanged after abolishing preparative fasting. Traditional preparatory fasting should be discontinued and reserved only for certain specific imaging tests.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article